PUMA BIOTECHNOLOGY, INC.

PBYI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $81.7M $194.5M $31.6M $38.5M $43.0M $137.4M $53.4M $0
Accounts Receivable $9.7M
Inventory $2.0M
Total Current Assets $106.4M $236.5M $223.5M $149.4M $96.4M $149.0M $53.7M
Property, Plant & Equipment $4.5M $5.2M $2.4M $2.2M $1.7M $1.5M $682.0K
Goodwill
Intangible Assets (Excl. Goodwill) $48.4M
Total Assets $165.5M $252.8M $239.8M $162.8M $104.4M $151.7M $55.4M
Liabilities
Accounts Payable $27.7M $20.0M $17.8M $15.0M $10.7M $482.0K $87.0K
Total Current Liabilities $58.3M $37.5M $32.4M $44.4M $19.3M $21.7M $587.0K
Long-Term Debt $48.5M
Total Liabilities $112.2M $43.0M $33.8M $45.7M $20.4M $22.8M $1.0M
Stockholders' Equity
Retained Earnings $-1.09B $-796.5M $-520.5M $-281.2M $-139.3M
Total Stockholders' Equity $53.3M $209.8M $206.0M $117.0M $84.0M $128.9M $54.4M
← Newer Page 2 of 2 Older →